Circadian misalignment may impact diabetes risk

Circadian misalignment may impact diabetes risk

(HealthDay)—Circadian misalignment decreases insulin sensitivity and increases inflammation, and is independent of sleep loss in men, according to a study published in the June issue of Diabetes.

Rachel Leproult, Ph.D., from the University of Chicago, and colleagues conducted a parallel group design study involving 26 adults. The authors sought to examine whether the misalignment of that typically occurs in shift work involves intrinsic adverse metabolic effects, independently of . The interventions involved three inpatient days with 10-hour bedtimes, followed by eight inpatient days with to five hours and fixed nocturnal bedtimes (circadian alignment), or with delayed bedtimes on four of the eight days with sleep restriction (circadian misalignment).

The researchers found that daily total sleep time was nearly identical in the aligned and misaligned conditions during the intervention (four hours 48 minutes versus four hours 45 minutes, respectively). Insulin sensitivity decreased significantly in both groups after sleep restriction, with no compensatory increase in insulin secretion; inflammation increased in both groups. The reduction in and increase in inflammation both doubled in male participants exposed to circadian misalignment compared with those who maintained regular nocturnal bedtimes.

"Circadian misalignment that occurs in shift work may increase diabetes risk and inflammation, independently of sleep loss," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

High-value research of 2014 presented for endocrinology

date May 04, 2015

(HealthDay)—Articles relating to diabetes and obesity, lipid management, bone metabolism, adrenal disorders, and thyroid disorders are included in a special endocrinology update summary published online ...

World first for artificial pancreas team

date May 01, 2015

The first natural birth to a mother with diabetes who has been fitted with an artificial pancreas took place this week. The device has been developed by researchers at the University of Cambridge.

Long-term post-CABG mortality increased with diabetes

date Apr 30, 2015

(HealthDay)—Patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) have increased long-term risk of death after coronary artery bypass grafting (CABG), with higher risk among ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.